Atlas Trials

Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP

Clinical trial NCT04720261 · TERMINATED

Trial details

NCT number
NCT04720261
Sponsor
University Hospital, Rouen
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Thrombotic Thrombocytopenic Purpura, Acquired
Start date
2021-04-26
Primary completion
2023-05-16
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.